NUS Medicine BSL-3 Core Facility Partners with Robert Koch Institute to Advance Global Health and Biorisk Capacity

The NUS Medicine BSL-3 Core Facility is honoured to be a key partner in a newly signed Memorandum of Understanding (MOU) with the Robert Koch Institute (RKI), Germany’s national public health institute. This strategic partnership aims to strengthen collaboration in biosafety, biosecurity, and global health through joint research, knowledge exchange, and workforce development.

The partnership marks a significant milestone in advancing pandemic preparedness and biorisk management capabilities in the region. The NUS Medicine BSL-3 Core Facility will play a pivotal role in supporting this initiative through its expertise in high-containment research, biosafety training, and capacity-building efforts.

Read more about this important collaboration here: Global health gets a boost with NUS-RKI strategic partnership